1 / 6

(2020-2030) Pegfilgrastim Biosimilars Market Size, Share, Growth And Trends

The major players covered in the global pegfilgrastim biosimilars market are Mylan, Biocon, Mundipharma, Pfizer, Sandoz, Coherus, Intas Pharmaceuticals, Fresenius Kabi Read More @ https://bit.ly/2G68Db2<br>

Télécharger la présentation

(2020-2030) Pegfilgrastim Biosimilars Market Size, Share, Growth And Trends

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Pegfilgrastim Biosimilars Global Market Report 2020-30: Covid 19 Growth And Change © The Business Research Company. All rights reserved.

  2. Pegfilgrastim Biosimilars Market Characteristics: Click Here To View Complete Report The global pegfilgrastim biosimilar market is expected to decline from $534.43 million in 2019 to $453.11 million in 2020 at a compound annual growth rate (CAGR) of -15.22%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $1,158.72 million in 2023 at a CAGR of 36.75%. The Business Research Company’s latest report Pegfilgrastim Biosimilars Global Market Report 2020 covers Pegfilgrastim Biosimilars market drivers, Pegfilgrastim Biosimilars market trends, Pegfilgrastim Biosimilars market segments, Pegfilgrastim Biosimilars market growth rate, Pegfilgrastim Biosimilars market major players, and Pegfilgrastim Biosimilars market size. The report provides in-depth analysis of the impact of COVID-19 on the Pegfilgrastim Biosimilars industry, along with revised market numbers due to the effects of the coronavirus. The report covers the Pegfilgrastim Biosimilars market’s segments- 1) By Application: Chemotherapy Treatment, Transplantation, Others 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Mail-Order Pharmacies The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. © The Business Research Company. All rights reserved.

  3. Major Key Players:Mylan, Biocon, Mundipharma, Pfizer, Sandoz Click Here To Get A Sample Report © The Business Research Company. All rights reserved.

  4. Table Of Content 1. Executive Summary 2. Pegfilgrastim Biosimilars Market Characteristics 3. Pegfilgrastim Biosimilars Market Size And Growth 4. Pegfilgrastim Biosimilars Market Segmentation 5. Pegfilgrastim Biosimilars Market Regional And Country Analysis ... 25. Pegfilgrastim Biosimilars Market Competitive Landscape And Company Profiles 26. Key Mergers And Acquisitions In The Pegfilgrastim Biosimilars Market 27. Pegfilgrastim Biosimilars Market Trends And Strategies 28. Pegfilgrastim Biosimilars Market Future Outlook and Potential Analysis 29. Appendix Click Here To Get A Sample Report The Business Research Company. All rights reserved.

  5. Get In Touch Whatever your need be, at The Business Research Company we provide research consulting solutions for businesses, government agencies consultancies, and market research companies. © The Business Research Company. All rights reserved.

  6. Americas The Business Research Company 625 South Avenue, Apt B204, Secane, Philadelphia, PA 19018, USA +1 3156230293 Email: info@tbrc.info www.tbrc.info Europe The Business Research Company 47 Anchorage Point, 42 Cuba Street, Canary Wharf, London, England, E14 8NE. +44 207 1930 708 Email: info@tbrc.info www.tbrc.info Asia The Business Research Company, Horizon Avenue, 8-2-603/b/s/1/2 Road Number 10 Banjara Hills Hyderabad (India) 500033 ++91 8897263534 Email: info@tbrc.info www.tbrc.info © The Business Research Company. All rights reserved.

More Related